Terex Corp: Form 10-K for the period ended Dec 31, 2025
Filed with the SEC on Feb 13, 2026 and accepted by EDGAR at Feb 13, 2026, 15:50 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2025-01-01 to 2025-12-31 | $5.42bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2025-01-01 to 2025-12-31 | $4.37bn | us-gaap:CostOfRevenue |
| Gross profit | 12 months2025-01-01 to 2025-12-31 | $1.05bn | us-gaap:GrossProfit |
| Research and development | 12 months2025-01-01 to 2025-12-31 | $39.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2025-01-01 to 2025-12-31 | $576.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2025-01-01 to 2025-12-31 | $475.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2025-01-01 to 2025-12-31 | $177.0m | us-gaap:InterestExpense |
| Income tax | 12 months2025-01-01 to 2025-12-31 | $71.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2025-01-01 to 2025-12-31 | $221.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2025-01-01 to 2025-12-31 | $3.33 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2025-01-01 to 2025-12-31 | $3.36 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2025-01-01 to 2025-12-31 | 66,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2025-01-01 to 2025-12-31 | $440.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2025-01-01 to 2025-12-31 | $118.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 12 months2025-01-01 to 2025-12-31 | $45.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2025-01-01 to 2025-12-31 | $56.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-12-31 | $772.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-12-31 | $2.73bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $6.14bn | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $1.19bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-12-31 | $4.04bn | us-gaap:Liabilities |
| Current portion of debt | At period end2025-12-31 | $6.0m | us-gaap:DebtCurrent |
Source: SEC EDGAR, the filing index for accession 0000097216-26-000035. Last ingested by Listed: Nov 12, 2026, 19:18 ET. Listed shows no prices and gives no investment advice.